@article{c52da173048a4f178d9b9fbd3f337315,
title = "Genome editing technologies and their potential to treat neurologic disease",
author = "Madigan, \{Nicolas N.\} and Staff, \{Nathan P.\} and Windebank, \{Anthony J.\} and Benarroch, \{Eduardo E.\}",
note = "Funding Information: N.N. Madigan receives stipend support from the Mayo Clinic Graduate School of Medical Education. N.P. Staff receives grants from the National Cancer Institute and National Center for Advancing Translational Sciences, Regenerative Medicine Minnesota, and BrainStorm Cell Therapeutics. A.J. Windebank receives grants from the National Institute of Aging, National Center for Advancing Translational Sciences, Armed Forces Institute of Regenerative Medicine, Regenerative Medicine Minnesota, Morton Cure Paralysis Fund, Craig H. Neilsen Foundation, The Bowen Family Foundation, The Judith and Jean Pape Adams Foundation, Mayo Clinic Center for Regenerative Medicine, and research funding from BrainStorm Cell Therapeutics. E.E. Benarroch receives a stipend in his capacity as section editor of Clinical Implications of Neuroscience Research for Neurology{\textregistered}. Go to Neurology.org for full disclosures.",
year = "2017",
month = oct,
day = "17",
doi = "10.1212/WNL.0000000000004558",
language = "English (US)",
volume = "89",
pages = "1739--1748",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "16",
}